Lithium Ion

Lithium Ion

SCHEMBL31299007

CN(C(=O)OCc1ccccc1)C(Cc1ccccc1)C(=O)[O-].[Li+]

nearest known ligand 0.54

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Lithium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ABCB1 P08183 2/20 0.54
▸ P2RX7 Q99572 1/20 0.48
▸ ITGB3 P05106 1/20 0.48
▸ ITGA2B P08514 1/20 0.48
▸ ALDH1A1 P00352 5/20 0.45
▸ ALPL P05186 1/20 0.44
▸ POLB P06746 1/20 0.44
▸ ALPG P10696 1/20 0.44
▸ CTRB1 P17538 2/20 0.44
▸ CTSL P07711 2/20 0.43
▸ CTSB P07858 2/20 0.43
▸ CTSS P25774 2/20 0.43
▸ CTSK P43235 2/20 0.43
▸ MAPT P10636 2/20 0.43
▸ HPGD P15428 1/20 0.43
▸ GAA P10253 1/20 0.42
▸ MAPK1 P28482 1/20 0.41
▸ HTT P42858 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lithium Ion SCHEMBL30679693 1.00 ABCB1 (0.54) ABCB1P2RX7ITGB3ITGA2BALDH1A1
SCHEMBL8067076 0.87 ITGB3 (0.59) ABCB1P2RX7ITGB3ITGA2BALDH1A1
SCHEMBL2968658 0.87 ITGB3 (0.59) ABCB1P2RX7ITGB3ITGA2BALDH1A1
SCHEMBL31739224 0.87 ITGB3 (0.59) ABCB1P2RX7ITGB3ITGA2BALDH1A1
SCHEMBL2494968 0.87 ITGB3 (0.59) ABCB1P2RX7ITGB3ITGA2BALDH1A1
SCHEMBL26654521 0.86 ITGB3 (0.58) ABCB1P2RX7ITGB3ITGA2BALDH1A1
SCHEMBL26654515 0.86 ITGB3 (0.58) ABCB1P2RX7ITGB3ITGA2BALDH1A1
SCHEMBL22457646 0.84 ABCB1 (0.62) ABCB1P2RX7ITGB3ITGA2BALDH1A1
SCHEMBL25183099 0.84 ITGB3 (0.57) ABCB1P2RX7ITGB3ITGA2BALDH1A1
SCHEMBL30688544 0.82 ITGB3 (0.58) ABCB1P2RX7ITGB3ITGA2BALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250368680-A1 METHOD FOR PRODUCING SALT OF AMINO ACID OR SALT OF PEPTIDE COMPOUND OR SOLVATE OF EITHER ONE OF SAID SALTS COMPRISING LITHIUM SALT PRECIPITATION STEP CHUGAI PHARMACEUTICAL CO LTD (JP) 2025-12-04 — — US disclosed
CN-119156373-A Method for producing salts of amino acids or salts of peptide compounds or solvates of any of the salts comprising a lithium salt precipitation step 中外制药株式会社 2024-12-17 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250368680-A1 METHOD FOR PRODUCING SALT OF AMINO ACID OR SALT OF PEPTIDE COMPOUND OR SOLVATE OF EITHER ONE OF SAID SALTS COMPRISING LITHIUM SALT PRECIPITATION STEP NPPA, DNPEP, NPEPPS ABCB1 4843/4885P2RX7 4606/4885ITGB3 4488/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback